Twin Tree Management LP Takes $4.26 Million Position in Hologic, Inc. (HOLX)

Twin Tree Management LP bought a new stake in shares of Hologic, Inc. (NASDAQ:HOLX) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 107,157 shares of the medical equipment provider’s stock, valued at approximately $4,259,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of HOLX. Jane Street Group LLC increased its holdings in shares of Hologic by 30.3% in the 1st quarter. Jane Street Group LLC now owns 6,904 shares of the medical equipment provider’s stock valued at $258,000 after acquiring an additional 1,607 shares during the period. United Capital Financial Advisers LLC increased its holdings in shares of Hologic by 34.4% in the 1st quarter. United Capital Financial Advisers LLC now owns 6,395 shares of the medical equipment provider’s stock valued at $239,000 after acquiring an additional 1,638 shares during the period. Amalgamated Bank increased its holdings in shares of Hologic by 4.6% in the 1st quarter. Amalgamated Bank now owns 37,694 shares of the medical equipment provider’s stock valued at $1,408,000 after acquiring an additional 1,674 shares during the period. AdvisorNet Financial Inc increased its holdings in shares of Hologic by 19.0% in the 2nd quarter. AdvisorNet Financial Inc now owns 10,477 shares of the medical equipment provider’s stock valued at $416,000 after acquiring an additional 1,675 shares during the period. Finally, Thompson Investment Management Inc. increased its holdings in shares of Hologic by 2.2% in the 2nd quarter. Thompson Investment Management Inc. now owns 82,333 shares of the medical equipment provider’s stock valued at $3,273,000 after acquiring an additional 1,753 shares during the period. 93.34% of the stock is owned by institutional investors and hedge funds.

HOLX stock traded down $0.12 on Thursday, hitting $38.29. 13,983 shares of the company’s stock were exchanged, compared to its average volume of 2,419,643. Hologic, Inc. has a 12-month low of $35.10 and a 12-month high of $45.09. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.29 and a quick ratio of 0.99. The company has a market cap of $11.06 billion, a price-to-earnings ratio of 18.89, a price-to-earnings-growth ratio of 1.85 and a beta of 0.74.

Hologic (NASDAQ:HOLX) last announced its earnings results on Tuesday, July 31st. The medical equipment provider reported $0.58 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.56 by $0.02. Hologic had a positive return on equity of 22.18% and a negative net margin of 2.47%. The firm had revenue of $824.00 million for the quarter, compared to the consensus estimate of $800.14 million. equities research analysts anticipate that Hologic, Inc. will post 2.24 earnings per share for the current year.

A number of brokerages have recently issued reports on HOLX. BidaskClub downgraded Hologic from a “hold” rating to a “sell” rating in a report on Thursday. Canaccord Genuity cut their price target on Hologic from $42.00 to $41.00 and set a “hold” rating on the stock in a report on Tuesday. Needham & Company LLC reiterated a “buy” rating and issued a $48.00 price target on shares of Hologic in a report on Monday. Zacks Investment Research upgraded Hologic from a “sell” rating to a “hold” rating in a report on Thursday, August 2nd. Finally, BTIG Research reiterated a “buy” rating and issued a $47.00 price target on shares of Hologic in a report on Thursday, August 2nd. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and nine have assigned a buy rating to the company. Hologic currently has a consensus rating of “Hold” and an average target price of $45.47.

In related news, insider Peter J. Valenti III sold 10,107 shares of the business’s stock in a transaction on Tuesday, May 29th. The stock was sold at an average price of $38.52, for a total transaction of $389,321.64. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.88% of the stock is owned by insiders.

Hologic Profile

Hologic, Inc develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company operates through five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health.

Recommended Story: What do investors mean by earnings per share?

Want to see what other hedge funds are holding HOLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hologic, Inc. (NASDAQ:HOLX).

Institutional Ownership by Quarter for Hologic (NASDAQ:HOLX)

Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply